Glaukos

Glaukos FCF Margin

The Free Cash Flow Margin of Glaukos (GKOS) as of Oct 28, 2026 is -10.64 %. In the previous year, Free Cash Flow Margin was -17.63 % — a change of -39.64% (higher).

FCF Margin

-10.64 %

YoY

-39.64%

Last updated:

Free Cash Flow Margin of Glaukos is 2025 -10.64 % . Free Cash Flow Margin of Glaukos was 2024 -17.63 % . It decreases by -39.64% higher compared to the previous year.

The Glaukos FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2018
4.72 USD
Jan 1, 2019
-2.15 USD
Jan 1, 2020
-13.30 USD
Jan 1, 2021
-7.85 USD
Jan 1, 2022
-22.40 USD
Jan 1, 2023
-24.79 USD
Jan 1, 2024
-17.63 USD
Jan 1, 2025
-10.64 USD
The Glaukos FCF Margin history
YEARFCF MarginYoY
-10.64 %-39.64%
-17.63 %-28.86%
-24.79 %+10.68%
-22.40 %+185.33%
-7.85 %-40.99%
-13.30 %+518.94%
-2.15 %-145.57%
4.72 %-60.88%
12.05 %+128.65%
5.27 %-223.33%
-4.27 %-75.56%
-17.49 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Glaukos Stock analysis

What does Glaukos do? Glaukos Corp is a medical technology company specializing in developing devices and therapies for treating eye diseases. It was founded in 1998 by employees of the ophthalmology center at the University of California San Francisco. The company focuses on utilizing new technologies and therapies to improve the vision quality of patients. They have developed innovative products for diagnosing and treating various eye conditions, including glaucoma. Their core business involves manufacturing and distributing medical devices for glaucoma treatment, such as the iStent implant. They have also partnered with other institutions to advance research and development in the field of ophthalmology. In 2018, Glaukos Corp acquired the German manufacturer Markt II Medical, expanding their product offerings for a wider range of eye diseases. In summary, Glaukos Corp is an innovative medical technology company that aims to enhance patients' vision quality while minimizing the risks of eye surgery. Glaukos is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Glaukos stock

Free Cash Flow Margin of Glaukos is -10.64 % in 2025.

Free Cash Flow Margin of Glaukos changed from -17.63 % to -10.64 %, representing a -39.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Glaukos since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Glaukos with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Glaukos

All Key Metrics — Glaukos